Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-04-19
2011-04-19
Strzelecka, Teresa E (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C435S287200, C536S023100, C536S024300, C977S792000
Reexamination Certificate
active
07927795
ABSTRACT:
Gene expression profiling and hierarchal clustering analysis readily distinguish normal ovarian epithelial cells from primary ovarian serous papillary carcinomas. Laminin, tumor-associated calcium signal transducer 1 and 2 (TROP-1/Ep-CAM; TROP-2), claudin 3, claudin 4, ladinin 1, S100A2, SERPIN2 (PAI-2), CD24, lipocalin 2, osteopontin, kallikrein 6 (protease M), kallikrein 10, matriptase and stratifin were found among the most highly overexpressed genes in ovarian serous papillary carcinomas, whereas transforming growth factor beta receptor III, platelet-derived growth factor receptor alpha, SEMACAP3, ras homolog gene family, member I (ARHI), thrombospondin 2 and disabled-2/differentially expressed in ovarian carcinoma 2 (Dab2/DOC2) were significantly down-regulated. Therapeutic strategy targeting TROP-1/Ep-CAM by monoclonal chimeric/humanized antibodies may be beneficial in patients harboring chemotherapy-resistant ovarian serous papillary carcinomas.
REFERENCES:
Lu, K.H. et al., Clin. Cancer Res., vol. 10, pp. 3291-3300 (2004).
Hibbs, K. et al., Am. J. Pathol., vol. 165, pp. 397-414 (2004).
Zorn, K. et al., Clin. Cancer Res., vol. 11, pp. 6422-6430 (2005).
Meinhold-Heerlein, I. et al., Oncogene, vol. 24, pp. 1053-1065 (2005).
Donninger, H. et al., Oncogene, vol. 23, pp. 8065-8077 (2004).
Olivier, R.I. et al, Eur. J. Cancer, vol. 42, pp. 2930-2938 (2006).
Zorn, K. et al., Clin. Cancer Res., vol. 9, pp. 4811-4818 (2003).
OMIM Database, PAI2, downloaded Oct. 28, 2009.
Hough, C.D. et al., Cancer Res., vol. 60, pp. 6281-6287 (2000).
Sawiris et al., Cancer Res., vol. 62, pp. 2923-2928 (2002).
Adler Benjamin Aaron
Board of Trustees of the University of Arkansas
Strzelecka Teresa E
LandOfFree
Gene expression profiling in primary ovarian serous... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression profiling in primary ovarian serous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression profiling in primary ovarian serous... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666034